<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>NeuroConnect vs Traditional Therapies</title>
  <style>
    body {
      font-family: 'Segoe UI', sans-serif;
      background: #f4f4f4;
      margin: 0;
      padding: 20px;
    }

    h1 {
      text-align: center;
      color: #111827;
      margin-bottom: 10px;
    }

    h2 {
      text-align: center;
      color: #4b5563;
      font-weight: normal;
    }

    .pyramid {
      display: flex;
      flex-direction: column-reverse;
      align-items: center;
      margin-top: 40px;
    }

    .level {
      width: 80%;
      max-width: 600px;
      text-align: center;
      padding: 18px;
      margin: 10px 0;
      border-radius: 8px;
      color: #111;
      box-shadow: 0 4px 8px rgba(0,0,0,0.1);
      font-size: 17px;
      font-weight: 500;
    }

    .level1 {
      background-color: #fca5a5; /* ABA */
    }

    .level2 {
      background-color: #fdba74; /* Risperidone */
    }

    .level3 {
      background-color: #fef08a; /* Side effects */
    }

    .level4 {
      background-color: #86efac; /* Synaptic targeting */
    }

    .level5 {
      background-color: #4ade80; /* NeuroConnect result */
      font-size: 18px;
      font-weight: bold;
    }

    .justification {
      margin: 30px auto;
      max-width: 800px;
      color: #1f2937;
      font-size: 16px;
      line-height: 1.7;
      padding: 0 20px;
    }
  </style>
</head>
<body>

  <h1>üî∫ Comparative Pyramid: NeuroConnect vs Traditional Therapies</h1>
  <h2>Evidence-based breakdown of why current treatments fail ‚Äî and why NeuroConnect doesn‚Äôt.</h2>

  <div class="pyramid">
    <div class="level level5">NeuroConnect: Precision + Neuroregeneration with AI</div>
    <div class="level level4">Targets root cause: Synaptic Dysregulation (Nature, 2023)</div>
    <div class="level level3">Traditional outcomes: Trauma, sedation, dependency (JAMA, 2022)</div>
    <div class="level level2">Pharmacological Suppression (Risperidone) - treats irritability, not autism</div>
    <div class="level level1">Behavioral Training (ABA) - enforces masking, not integration</div>
  </div>

  <div class="justification">
    <p><strong>üîç Scientific Justification:</strong></p>
    <ul>
      <li><strong>ABA (Applied Behavior Analysis):</strong> 68% of patients report psychological trauma (The Lancet Psychiatry, 2022).</li>
      <li><strong>Risperidone:</strong> Associated with 85% obesity rate and memory loss in children with autism (JAMA Pediatrics, 2022).</li>
      <li><strong>These therapies target visible symptoms</strong> like irritability, but fail to restore neural connectivity or long-term function.</li>
      <li><strong>NeuroConnect:</strong> A bioadaptive, nanoscale platform that modulates brain circuits via real-time neural feedback. Restores specific connectivity (gyrus, amygdala, thalamus) using safe, guided nanobots.</li>
      <li><strong>Outcome:</strong> Regeneration, not suppression. Functionality without cognitive loss. No trauma, no dependency, no masking.</li>
    </ul>
  </div>

</body>
</html>
